A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

Clinical trial NCT06554639 · COMPLETED

Trial details

NCT number: NCT06554639
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2024-07-11
Primary completion: 2024-08-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.